Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 08:26 am Purchase | 2022-12-31 | 13G | MoonLake Immunotherapeutics MLTX | Citadel Advisors LLC | 2,886,092 7.400% | 2,886,092 (New Position) | Filing History |
| 2023-02-09 12:48 pm Purchase | 2023-02-09 | 13G | MoonLake Immunotherapeutics MLTX | FMR LLC | 1,193,000 3.230% | 1,193,000 (New Position) | Filing History |
| 2023-02-09 10:09 am Unchanged | 2022-12-31 | 13G | MoonLake Immunotherapeutics MLTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-01-27 06:13 am Purchase | 2022-12-31 | 13G | Helix Acquisition Corp. HLXA | Merck Healthcare KGaA | 3,330,231 7.900% | 3,330,231 (New Position) | Filing History |
| 2022-08-03 06:17 am Purchase | 2022-08-06 | 13G | MoonLake Immunotherapeutics MLTX | Merck Healthcare KGaA | 3,330,231 8.300% | 3,330,231 (New Position) | Filing History |
| 2022-04-18 4:49 pm Purchase | 2022-04-05 | 13D | MoonLake Immunotherapeutics MLTX | BIOTECHNOLOGY VALUE FUND L P | 21,751,284 58.900% | 21,751,284 (New Position) | Filing History |
| 2022-02-14 2:35 pm Sale | 2021-12-31 | 13G | Helix Acquisition Corp. HLXA | T. Rowe Price Associates, Inc. | 746,862 6.200% | -40,923 (-5.19%) | Filing History |
| 2022-02-14 06:12 am Sale | 2021-12-31 | 13G | Helix Acquisition Corp. HLXA | Citadel Advisors LLC | 686,007 5.800% | -1,071 (-0.16%) | Filing History |
| 2022-02-03 4:41 pm Sale | 2021-12-31 | 13G | MoonLake Immunotherapeutics MLTX | BlackRock Inc. BLK | 741,906 6.200% | -8,247 (-1.10%) | Filing |
| 2021-12-10 08:52 am Purchase | 2021-12-09 | 13G | Helix Acquisition Corp. HLXA | FMR LLC | 1,193,000 10.000% | 1,193,000 (New Position) | Filing History |
| 2021-11-15 4:34 pm Sale | 2021-11-15 | 13G | Helix Acquisition Corp. HLXA | RA Capital Management, L.P. | 0 0.000% | -700,000 (Position Closed) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Helix Acquisition Corp. HLXA | RA Capital Management, L.P. | 700,000 5.900% | 700,000 (New Position) | Filing History |
| 2021-02-16 4:30 pm Sale | 2020-12-31 | 13G | Helix Acquisition Corp. HLXA | Citadel Advisors LLC | 687,078 5.800% | -841 (-0.12%) | Filing History |
| 2021-02-16 12:24 pm Purchase | 2020-12-31 | 13G | Helix Acquisition Corp. HLXA | T. Rowe Price Associates, Inc. | 787,785 5.300% | 787,785 (New Position) | Filing History |
| 2021-02-16 10:35 am Purchase | 2020-12-31 | 13G | Helix Acquisition Corp. HLXA | RTW Investments, LP | 750,000 6.290% | 750,000 (New Position) | Filing History |
| 2021-02-11 07:45 am Purchase | 2020-12-31 | 13G | Helix Acquisition Corp. HLXA | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,011,589 8.480% | 4,504 (+0.45%) | Filing History |
| 2021-02-05 5:51 pm Purchase | 2020-12-31 | 13G | MoonLake Immunotherapeutics MLTX | BlackRock Inc. BLK | 750,153 6.300% | 750,153 (New Position) | Filing |